Cisplatin-enhanced sensitivity of glioblastoma multiforme U251 cells to adenovirus-delivered TRAIL in vitro.

Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine
Jian ChenXingang Li

Abstract

TRAIL is a novel therapeutic agent for potential use in glioblastoma multiforme therapy; however, glioblastoma multiforme cells exhibit resistance to TRAIL-induced apoptosis. To evaluate the effects of cisplatin on sensitivity of human glioma cell line U251 to Ad-TRAIL and to investigate the potential mechanism, U251 cells were transfected with Ad-TRAIL and then exposed to cisplatin. The proliferation inhibition of the treated cells was studied by the method of MTT. The cell apoptosis was analyzed by Hoechst33342 staining and by flow cytometry with propidium iodide staining. Semi-quantitative RT-PCR was introduced to detect the mRNA expression of TRAIL, DR4, DR5, Caspase 3, and survivin. Protein expression of DR5 and cleaved Caspase 3 was detected by Western blot assay. The results showed that the combination treatment of cisplatin and Ad-TRAIL could inhibit the proliferation of U251 cells significantly compared with the alone treatment (P < 0.01), which was chiefly attributed to the induction of obvious apoptosis. The enhancement of Ad-TRAIL by cisplatin was due to the up-regulation of DR5 but not DR4 expression, and followed by the down-regulation of survivin and activation of Caspase 3. In conclusion, cisplatin could enhance...Continue Reading

References

Apr 3, 2001·Nature Medicine·D LawrenceA Ashkenazi
Jun 6, 2003·Cytokine & Growth Factor Reviews·Alexandru Almasan, Avi Ashkenazi
Oct 27, 2004·Cancer Science·Hideo YagitaKo Okumura
Oct 1, 2005·Gene Therapy·C-Y KimD-W Seol
Oct 4, 2005·Molecular and Cellular Biology·Amith PannerRussell O Pieper
Aug 1, 2006·Critical Reviews in Oncology/hematology·Carsten NiederAnca L Grosu
Dec 16, 2006·Journal of Neuro-oncology·H Christopher LawsonHenry Brem
Apr 14, 2007·Molecular Cancer Therapeutics·Subrata RayAlexandru Almasan
Sep 6, 2007·Brain : a Journal of Neurology·Dietmar KrexUNKNOWN German Glioma Network
Mar 11, 2008·Cancer Letters·Frank A E Kruyt
Apr 1, 2008·Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy·Andrew ThorburnHeide Ford
Sep 25, 2008·Nature Reviews. Cancer·Ricky W JohnstoneMark J Smyth

❮ Previous
Next ❯

Citations

Feb 3, 2016·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Lin LiJia-Fu Ji
Oct 26, 2013·Artificial Cells, Nanomedicine, and Biotechnology·Yihe DouQinghai Meng
Apr 4, 2021·Cancers·Olivia A Diaz Arguello, Hidde J Haisma
May 1, 2021·Biomolecules·Longfei DengHongjuan Cui

❮ Previous
Next ❯

Related Concepts

Related Feeds

CREs: Gene & Cell Therapy

Gene and cell therapy advances have shown promising outcomes for several diseases. The role of cis-regulatory elements (CREs) is crucial in the design of gene therapy vectors. Here is the latest research on CREs in gene and cell therapy.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis